Video

Study explores relationship between testosterone and frailty in the operative setting

Author(s):

Urology Times staff

In this video, Joshua Halpern, MD, discusses the abstract, “Association of low testosterone and frailty among veterans undergoing cancer surgery,” which he presented at the 2022 AUA Annual Meeting. Halpern is an assistant professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Related Videos
Justin Dubin, MD, answers a question during a video interview
Man talking with a doctor | Image Credit: © RFBSIP - stock.adobe.com
Related Content
Men with severe ED more than twice likely to have high ceramide levels
October 18th 2024

Men with severe ED more than twice likely to have high ceramide levels

Kevin Kunzmann
New research better defines the link between cardiovascular disease risk and prevalence of ED per serum ceramide levels.
The urologist's role in dispelling men's health myths
May 10th 2022

The urologist's role in dispelling men's health myths

Urology Times staff
“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.
Survey reveals generational trends in men’s health habits
September 5th 2024

Survey reveals generational trends in men’s health habits

Hannah Clarke
“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD.
Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes
March 7th 2022

Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes

Urology Times staff
“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.
Novel classification system proposed for Peyronie disease, penile curvature
August 9th 2024

Novel classification system proposed for Peyronie disease, penile curvature

Hannah Clarke
"We propose a new classification system, which we believe will provide a more consistent and standardized approach to classification and treatment of PD," says Landon Trost, MD.
Approval sought for testosterone undecanoate in Canada
July 31st 2024

Approval sought for testosterone undecanoate in Canada

Hannah Clarke
A decision on the NDS for testosterone undecanoate is expected in Q2 of 2025.
© 2024 MJH Life Sciences

All rights reserved.